BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 17870449)

  • 1. Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
    Kempe S; Metz H; Bastrop M; Hvilsom A; Contri RV; Mäder K
    Eur J Pharm Biopharm; 2008 Jan; 68(1):26-33. PubMed ID: 17870449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat-induced transfer of protons from chitosan to glycerol phosphate produces chitosan precipitation and gelation.
    Lavertu M; Filion D; Buschmann MD
    Biomacromolecules; 2008 Feb; 9(2):640-50. PubMed ID: 18186608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels.
    Ahmadi R; de Bruijn JD
    J Biomed Mater Res A; 2008 Sep; 86(3):824-32. PubMed ID: 18041728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ph- and thermosensitive hydrogel as a vehicle for controlled protein delivery.
    Shi W; Ji Y; Zhang X; Shu S; Wu Z
    J Pharm Sci; 2011 Mar; 100(3):886-95. PubMed ID: 20862775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of functional chitosan thermosensitive hydrogel for slow release both rhBMP-2 and chlorhexidine].
    Ma ZW; Wang R; Wu ZF; Chen D; Zhang BL; He W; Wang XJ; Liu Q; Xu J; Zhu H
    Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):1049-54. PubMed ID: 18257235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical gelation of chitosan in the presence of beta-glycerophosphate: the effect of temperature.
    Cho J; Heuzey MC; Bégin A; Carreau PJ
    Biomacromolecules; 2005; 6(6):3267-75. PubMed ID: 16283755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin.
    Peng Q; Sun X; Gong T; Wu CY; Zhang T; Tan J; Zhang ZR
    Acta Biomater; 2013 Feb; 9(2):5063-9. PubMed ID: 23036950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphology and gelation of thermosensitive chitosan hydrogels.
    Crompton KE; Prankerd RJ; Paganin DM; Scott TF; Horne MK; Finkelstein DI; Gross KA; Forsythe JS
    Biophys Chem; 2005 Aug; 117(1):47-53. PubMed ID: 15905019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of in situ gel system for nasal insulin delivery.
    Agrawal AK; Gupta PN; Khanna A; Sharma RK; Chandrawanshi HK; Gupta N; Patil UK; Yadav SK
    Pharmazie; 2010 Mar; 65(3):188-93. PubMed ID: 20383938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
    Radivojša M; Grabnar I; Ahlin Grabnar P
    Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel thermoresponsive hydrogel based on chitosan.
    Schuetz YB; Gurny R; Jordan O
    Eur J Pharm Biopharm; 2008 Jan; 68(1):19-25. PubMed ID: 17884402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro insulin release from thermosensitive chitosan hydrogel.
    Khodaverdi E; Tafaghodi M; Ganji F; Abnoos K; Naghizadeh H
    AAPS PharmSciTech; 2012 Jun; 13(2):460-6. PubMed ID: 22391886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility evaluation of chitosan-based injectable hydrogels for the culturing mice mesenchymal stem cells in vitro.
    Yan J; Yang L; Wang G; Xiao Y; Zhang B; Qi N
    J Biomater Appl; 2010 Mar; 24(7):625-37. PubMed ID: 19451182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer.
    Kim S; Nishimoto SK; Bumgardner JD; Haggard WO; Gaber MW; Yang Y
    Biomaterials; 2010 May; 31(14):4157-66. PubMed ID: 20185170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
    Wu J; Wei W; Wang LY; Su ZG; Ma GH
    Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery.
    Supper S; Anton N; Boisclair J; Seidel N; Riemenschnitter M; Curdy C; Vandamme T
    Eur J Pharm Biopharm; 2014 Oct; 88(2):361-73. PubMed ID: 24859306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration.
    Besheer A; Wood KM; Peppas NA; Mäder K
    J Control Release; 2006 Mar; 111(1-2):73-80. PubMed ID: 16460830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable chitosan hydrogels for localised cancer therapy.
    Ta HT; Dass CR; Dunstan DE
    J Control Release; 2008 Mar; 126(3):205-16. PubMed ID: 18258328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart gelation of chitosan solution in the presence of NaHCO3 for injectable drug delivery system.
    Liu L; Tang X; Wang Y; Guo S
    Int J Pharm; 2011 Jul; 414(1-2):6-15. PubMed ID: 21554937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable Chitosan/β-Glycerophosphate System for Sustained Release: Gelation Study, Structural Investigation, and Erosion Tests.
    Dalmoro A; Abrami M; Galzerano B; Bochicchio S; Barba AA; Grassi M; Larobina D
    Curr Drug Deliv; 2017; 14(2):216-223. PubMed ID: 27440070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.